CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Open-market sale Director sold 136,112 shares at an average $29.30 ($3,988,016)
- 4 Grant or award Chief Commercial Officer acquired 37,800 shares (grant or award)
- 4 Open-market sale Director sold 138,845 shares at an average $29.38 ($4,079,361)
- 4 Grant or award SVP, Head of Finance & Admin. acquired 32,700 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 48,000 shares (grant or award)
- 4 Grant or award CEO & President acquired 145,300 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 66,500 shares (grant or award)
- 4 Open-market sale Director sold 110,933 shares at an average $29.50 ($3,273,008)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 16,500 shares at $28.73 ($474,045)
- 4 Open-market sale Director sold 782 shares at $33.10 ($25,884)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Head of Finance & Admin. sold 2,735 shares at $28.20 ($77,127)
- 4 Planned sale Chief Scientific Officer sold 2,856 shares at $28.20 ($80,539)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 15 of 40 · 796 filings